![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1498659
¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º ½ÃÀå Á¶»ç º¸°í¼ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)Global Cholesterol Testing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 260¾ï 6,000¸¸ ´Þ·¯¿¡¼ 2032³â¿¡´Â 550¾ï 4,000¸¸ ´Þ·¯ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2024-2032³â CAGRÀº 8.66%ÀÔ´Ï´Ù.
ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º´Â ÃÑ ÄÝ·¹½ºÅ×·Ñ, HDL(°í¹Ðµµ Áö´Ü¹é), LDL(Àú¹Ðµµ Áö´Ü¹é), Áß¼ºÁö¹æÀ¸·Î ±¸¼ºµÈ Ç÷Áß ÁöÁú ¼öÄ¡¸¦ ÃøÁ¤ÇÏ´Â Áø´Ü Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â ½ÉÇ÷°ü°è °Ç° »óŸ¦ Æò°¡ÇÏ°í ½ÉÀ庴 ¹× ³úÁ¹Áß À§ÇèÀ» ÆÄ¾ÇÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀϹÝÀûÀ¸·Î ½ÇÇè½Ç, º´¿ø ¶Ç´Â °¡Á¤¿ë °Ë»ç ŰƮ¸¦ ÅëÇØ ½ÃÇàµÇ´Â ÀÌ·¯ÇÑ ¼ºñ½º´Â °³ÀÎÀÌ ÄÝ·¹½ºÅ×·Ñ ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇϰí Á¤º¸¿¡ ÀÔ°¢ÇÑ »ýȰ½À°ü ¹× Ä¡·á °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. Á¤±âÀûÀÎ ÄÝ·¹½ºÅ×·Ñ °Ë»ç´Â °íÁöÇ÷ÁõÀ» Á¶±â¿¡ ¹ß°ßÇϰí, ¿¹¹æ Á¶Ä¡¸¦ ¾È³»Çϰí, ÃÖÀûÀÇ ½ÉÀå °Ç°À» À¯ÁöÇϱâ À§ÇÑ ½ÄÀÌ¿ä¹ý, ¾à¹° Ä¡·á ¹× ±âŸ Ä¡·á ÁßÀ縦 ÅëÇØ »óŸ¦ °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.
°ü»óµ¿¸ÆÁúȯ, ¸»Ãʵ¿¸ÆÁúȯ, ³úÁ¹Áß°ú °°Àº ½ÉÇ÷°üÁúȯ(CVD)ÀÇ À¯º´·üÀÌ ±ÞÁõÇϰí ÀÖ´Â °¡¿îµ¥, ÁÂ½Ä »ýȰ½À°ü, ºÒ°Ç°ÇÑ ½Ä½À°ü, ºñ¸¸°ú °°Àº À§Çè¿äÀÎÀ¸·Î ÀÎÇØ ¿¹¹æÀû °Ç°°ü¸® ¹× Áúº´°ü¸® Àü·«ÀÇ Áß¿äÇÑ ¿ä¼Ò·Î ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º¿¡ ´ëÇÑ ½ÃÀå ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ ºÎ´ã Áõ°¡´Â ½ÉÇ÷°ü À§ÇèÀ» Æò°¡Çϰí Ä¡·á ¹æÄ§À» °áÁ¤Çϱâ À§ÇÑ ÀÏ»óÀûÀÎ ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¹× ¸ð´ÏÅ͸µÀÇ Á߿伺À» °Á¶ÇÏ¸ç °Ë»ç ¼ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. Áø´Ü ±â¼ú ¹× ÇöÀå °Ë»ç ÀåºñÀÇ ¹ßÀüÀ¸·Î Æí¸®ÇÏ°í ½Å¼ÓÇÑ ÄÝ·¹½ºÅ×·Ñ °Ë»ç°¡ °¡´ÉÇØÁ® ȯÀÚÀÇ Á¢±Ù¼º°ú ¼øÀÀµµ¸¦ ³ôÀ̰í, °Ë»ç ½Ã°£°ú ÀÇ·áºñ¸¦ Àý°¨ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ÄÝ·¹½ºÅ×·Ñ °ü¸®¿Í ½ÉÀå °Ç°ÀÇ Á߿伺¿¡ ´ëÇÑ ´ëÁßÀÇ Àνİú ±³À° Ä·ÆäÀÎ Áõ°¡´Â ¿¹¹æÀû °ËÁø ¹× Á¶±â °³ÀÔ ±¸»óÀ» ÃËÁøÇÔÀ¸·Î½á ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯È÷ ½ÅÈï °æÁ¦±Ç¿¡¼ ÀÇ·á ÀÎÇÁ¶ó¿Í 1Â÷ Áø·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ¸é¼ ´Ù¾çÇÑ ÀÓ»ó ȯ°æ¿¡¼ ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º¿¡ ´ëÇÑ È¯ÀÚ Á¢±Ù¼ºÀ» È®´ëÇÏ¿© ½ÃÀå ħÅõ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿¹¹æÀû °ËÁø ¹× ½ÉÇ÷°ü À§Çè Æò°¡¿¡ ´ëÇÑ Áö¿øÀûÀÎ ±ÔÁ¦ Á¤Ã¥ ¹× »óȯ ÇÁ·¹ÀÓ¿öÅ©´Â ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º¸¦ Á¦°øÇϵµ·Ï Àå·ÁÇÏ°í ½ÃÀå ¼ö¿ä¸¦ ÀÚ±ØÇÕ´Ï´Ù. ±×·¯³ª ³ôÀº ¼ºñ½º ºñ¿ë°ú Á¦ÇÑµÈ °Ë»ç ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀº ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
Á¶»ç ¸®Æ÷Æ®´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» Ä¿¹öÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇϰí, ¼¼°è ·¹º§¿¡¼ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ ÅøÀº ¼¼°èÀÇ ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º ½ÃÀå¿¡¼ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.
ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º ½ÃÀå º¸°í¼ÀÇ ÀÌ ¼½¼Ç¿¡¼´Â ±¹°¡ ¹× Áö¿ª ·¹º§ ºÎ¹®¿¡ °üÇÑ »ó¼¼ µ¥ÀÌÅ͸¦ Á¦°øÇϰí, ÀÌ¿¡ µû¶ó Àü·«°¡°¡ ÇâÈÄ ±âȸ¿Í ÇÔ²² °¢°¢ÀÇ Á¦Ç° ¹× ¼ºñ½ºÀÇ ´ë»óÃþÀ» ½Äº°Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.
º» ¼½¼Ç¿¡¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ & ¾ÆÇÁ¸®Ä«¿¡¼ ÄÝ·¹½ºÅ×·Ñ °Ë»ç ¼ºñ½º ½ÃÀåÀÇ ÇöÀç ¹× ÇâÈÄ ¼ö¿ä¸¦ °Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ À¯¸í Àü Áö¿ª¿¡¼ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä¡¤ÃßÁ¤¡¤¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. Value Market ResearchÀÇ Á¶»çÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü ¸®Æ÷Æ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
The global demand for Cholesterol Testing Services Market is presumed to reach the market size of nearly USD 55.04 Billion by 2032 from USD 26.06 Billion in 2023 with a CAGR of 8.66% under the study period 2024-2032.
Cholesterol testing services provide diagnostic evaluations to measure lipid levels in the blood, comprising total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein), and triglycerides. These tests are essential for assessing cardiovascular health and identifying heart disease and stroke risks. Typically conducted in clinical laboratories, hospitals, or through at-home testing kits, these services help individuals monitor their cholesterol levels and make informed lifestyle and treatment decisions. Regular cholesterol testing is vital for early detection of hyperlipidemia, guiding preventive measures, and managing conditions with dietary changes, medications, or other therapeutic interventions to maintain optimal heart health.
The surging prevalence of cardiovascular diseases (CVDs), such as coronary artery disease, peripheral artery disease, and stroke, attributed to risk factors like sedentary lifestyles, unhealthy dietary habits, and obesity, drives market demand for cholesterol testing services as a crucial component of preventive healthcare and disease management strategies. This growing disease burden underscores the importance of routine cholesterol screening and monitoring to assess cardiovascular risk and guide treatment decisions, fuelling market growth for testing services. Advancements in diagnostic technologies and point-of-care testing devices enable convenient and rapid cholesterol testing, enhancing patient access and compliance while reducing turnaround times and healthcare costs.
Additionally, increasing public awareness and education campaigns about the importance of cholesterol management and heart health contribute to market expansion by promoting preventive screening and early intervention initiatives. Moreover, expanding healthcare infrastructure and access to primary care services, particularly in emerging economies, drive market penetration by broadening patient access to cholesterol testing services in diverse clinical settings. Furthermore, supportive regulatory policies and reimbursement frameworks for preventive screenings and cardiovascular risk assessments encourage healthcare providers to offer cholesterol testing services, stimulating market demand. However, the high cost of services and limited access to testing facilities may challenge the market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cholesterol Testing Services. The growth and trends of Cholesterol Testing Services industry provide a holistic approach to this study.
This section of the Cholesterol Testing Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Cholesterol Testing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cholesterol Testing Services market include Abbott Laboratories, Accu Reference Medical Lab LLC, Atherotech Diagnostics Lab, Bio-Reference Laboratories Inc., Boston Heart Diagnostics Corporation, Cell Biolabs Inc., Clinical Reference Laboratory Inc., Eurofins Scientific, Mayo Clinic Laboratories, Quest Diagnostics Incorporated, Randox Laboratories Limited, Sonic Healthcare Limited, SpectraCell Laboratories Inc., Synlab Holding Deutschland GmbH, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.